A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors
Clinical trial NCT06728189 · RECRUITING
Trial details
- NCT number
- NCT06728189
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-14
- Primary completion
- 2026-10-17
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.